Target Corporation (TGT)
EV Nickel Provides Update on 2024 Exploration Plan - Initiates Diamond Drill Program on High Grade Target
NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA OR TO US WIRE SERVICES TORONTO, ON / ACCESSWIRE / June 17, 2024 / EV NICKEL INC. (TSX-V:EVNI) ("EVNi" or the "Company") is please to provide an update on its 2024 Exploration Plan and the commencement of diamond drilling on the Langmuir #2, high priority nickel target (see Figure 1).
New Nvidia Price Target Is Highest on Wall Street
The chip maker was gaining early Monday as Susquehanna analyst Christopher Rolland became its most bullish advocate.
Target Aims to Reverse Losses With Private-Label Goods, Price Cuts
Target reportedly lost market share in several of its key product categories in the first quarter. The retailer's share shrank in food and household goods, clothing, electronics, homewares and furniture — categories that collectively account for 60% of its revenue, Reuters reported Friday (June 14), citing data from market research firm GlobalData.
Target Shares Cross Below 200 DMA
In trading on Friday, shares of Target crossed below their 200 day moving average of $140.93, changing hands as low as $139.71 per share. Target shares are currently trading down about 3% on the day.
Target (TGT) Hikes Dividend by 1.8%: Key Insights for Investors
Target (TGT) increases its quarterly dividend to $1.12 per share, reflecting a 1.8% rise from the previous level and marking the company's 53rd consecutive year of annual dividend growth.
Target (TGT) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Target (TGT) have what it takes?
Cathie Wood, Ark Invest Set New $2,600 Price Target For Tesla: 'Every Car Becomes An AI-Powered Cash Flow Generation Machine'
Ark Invest CEO and founder Cathie Wood may be best known for her 2018 price prediction on Tesla Inc TSLA shares. The price prediction was heavily scrutinized but came true years later and helped boost the profile of Wood and the price of many Ark Invest ETFs.
Agios Pharmaceuticals: Potential Acquisition Target, Upcoming FDA Approvals, Promising Pipeline
Agios Pharmaceuticals develops therapies for rare diseases with a focus on Pyruvate Kinase activators like Pyrukynd for PK deficiency. AGIO is advancing its pipeline with research on Mitapivat for thalassemia and sickle cell disease, positioning itself for potential FDA approvals in 2025 and 2026. A $905 million upfront payment from Royalty Pharma is contingent on FDA approval of Vorasidenib by August 2024.
Target raises quarterly dividend by 1.8% to $1.12 a share
Target Corp. TGT, -1.57% said Wednesday it's raising its quarterly dividend by 1.8% to $1.12 a share from $1.10 previously. The new dividend is payable Sept.
Target, Dick's Sporting Goods facing pushback from investors for 'going woke'
A group of activist investors plans to criticize major retailers Target and Dick's Sporting Goods over "woke" policies at the companies' respective shareholder meetings on Wednesday.
Target Sales Slide: Hold Rating Amid Strategy Concerns
Target is facing declining sales due to inflation, high interest rates, and a shift in consumer spending toward services. The company is focusing on everyday essentials to win back customers, but still expects sales to remain flat to slightly up in the current quarter. Initiating coverage with a hold based on Target's lack of a strategic growth plan to revive sales and slowdown in consumer spending.
Nvidia's First Trading Day After Its Stock Split Brings Slight Gain and Price-Target Hikes
Nvidia (NVDA) shares finished 0.8% higher at $121.79 Monday in the stock's first day of split-adjusted trading after a 10-for-1 forward stock split, and several analysts raised their price targets for the stock.
